Delivery Order SPE2DB22D3501-SPE2DB25FXH10
Award Date 9/12/25
Potential Completion Date 9/15/25
Potential Value $2.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $2,763.00 to AmerisourceBergen Drug Corp for Pegasys 180 mcg/mL vials, with an ultimate completion date of August 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing contract vehicle with the DLA. This delivery...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $3,990.37 to AmerisourceBergen Drug Corp for the supply of Pegasys 180 mcg/ml vials. This competitively awarded, firm fixed-price delivery order was issued on August 25, 2025, with an ultimate completion date of August 26, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this pharmaceutical supply transaction. The award represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $2,752.23 to AmerisourceBergen Drug Corp for Pegasys 180 mcg/0.5 mL syringes on September 9, 2025, with completion scheduled for September 10, 2025. This firm fixed-price contract, which was not set aside for small business or other designated categories, represents a competitive award to the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $4,139.94 to AmerisourceBergen Drug Corp for Pegasys 180 mcg/mL vials, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation will be performed at the awardee's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, will deliver the...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $4,261.21 by the Defense Logistics Agency (DLA) for the supply of Pegasys 180 mcg/ml vials. The award, issued on July 28, 2025, is a firm fixed price contract with an ultimate completion date of July 29, 2025. This non-set-aside delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- This delivery order, valued at $6,855.38, was awarded to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Pegasys 180 mcg/0.5 mL syringes. The contract is a firm fixed price delivery order with an ultimate completion date of July 22, 2025, and represents a non-set-aside award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order falls under a child contract structure, leveraging the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,833.83 on September 2, 2025, for Pegasys 180 mcg/mL vials to support the Defense Logistics Agency's Medical Supply Chain. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 3, 2025, with performance taking place at the contractor's Conshohocken facility. The award carries no set-aside...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide PEGASYS 180 MCG/ML VIALML pharmaceuticals. The contract has a potential value of $8,220.18 and a completion date of January 26, 2024. This delivery order contract is issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued up to $999,999,999.00 through December 31, 2025. The...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,072.25 firm fixed-price delivery order contract provides for PEGASYS 180 MCG/ML VIALML, with a completion date of February 4, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award, valued at $3,598.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PEGASYS 180 MCG/ML VIALML, with a completion date of May 20, 2025. It is a firm-fixed-price delivery order contract, without any set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...